Metastatic hormone-sensitive prostate cancer (mHSPC) accounts for 12% of prostate cancers diagnosed in Guadeloupe according to the Guadeloupean cancer registry. Most published studies have been conducted on the Caucasian population, whereas data concerning mHSPC in the Afro-Caribbean population are lacking. We aimed to describe the patient characteristics and estimate the progression-free survival of men with mHSPC in an Afro-Caribbean population according to the available treatment.

中文翻译：

---

诊断时患有转移性激素敏感性前列腺癌的非洲裔加勒比男性的特征和无进展生存期

根据瓜德罗普癌症登记处，转移性激素敏感性前列腺癌 (mHSPC) 占瓜德罗普诊断出的前列腺癌的 12%。大多数已发表的研究都是针对高加索人群进行的，而缺乏关于非洲-加勒比人群中 mHSPC 的数据。我们旨在描述患者特征并根据可用的治疗方法估计非洲裔加勒比人群中 mHSPC 男性的无进展生存期。